Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes

Răzvan Cristescu(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jeeyun Lee(Samsung Medical Center), Michael Nebozhyn(Merck & Co., Inc., Rahway, NJ, USA (United States)), Kyoung‐Mee Kim(Samsung Medical Center), Jason C. Ting(Eli Lilly (United States)), Swee Seong Wong(Eli Lilly (United States)), Jiangang Liu(Eli Lilly (United States)), Yong Yue(Eli Lilly (United States)), Jian Wang(Eli Lilly (United States)), Kun Yu(Eli Lilly (United States)), Xiang S. Ye(Eli Lilly (United States)), In‐Gu Do(Samsung Medical Center), X. Shawn Liu, Lara Gong, Jake Fu, Jason Jin, Min Gew Choi(Samsung Medical Center), Tae Sung Sohn(Samsung Medical Center), Joon Ho Lee(Samsung Medical Center), Jae Moon Bae(Samsung Medical Center), Seung Tae Kim(Samsung Medical Center), Se Hoon Park(Samsung Medical Center), Insuk Sohn(Samsung Medical Center), Sin‐Ho Jung(Samsung Medical Center), Patrick Tan(National University of Singapore), Ronghua Chen(Merck & Co., Inc., Rahway, NJ, USA (United States)), James C.H. Hardwick(Merck & Co., Inc., Rahway, NJ, USA (United States)), Won Ki Kang(Samsung Medical Center), Mark Ayers(Merck & Co., Inc., Rahway, NJ, USA (United States)), Dai Hongyue(Merck & Co., Inc., Rahway, NJ, USA (United States)), Christoph Reinhard(Eli Lilly (United States)), Andrey Loboda(Merck & Co., Inc., Rahway, NJ, USA (United States)), Sung Kim(Samsung Medical Center), Amit Aggarwal(Eli Lilly (United States))
Nature Medicine
April 20, 2015
Cited by 2,237

Abstract


Related Papers

No related papers found

Powered by citation graph analysis